Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DROPBOX, INC. (DBX)

  • Business News
  • April 16, 2026, 20:04 UTC
  • 2
  • 1 comments

Dropbox to Announce First Quarter 2026 Earnings Results

Market reaction Comment Full text

INSIGHT ENTERPRISES INC (NSIT)

  • Business News
  • April 16, 2026, 20:02 UTC
  • 2
  • 1 comments

Insight Enterprises, Inc. to Report First Quarter 2026 Financial Results on May 7, 2026

Market reaction Comment Full text

Janux Therapeutics Inc (JANX)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Janux - Investor Relations - Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

Market reaction Comment Full text

Cerus Corporation (CERS)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Cerus Corporation - Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Market reaction Comment Full text

LAKELAND INDUSTRIES INC (LAKE)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Lakeland Fire + Safety Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Market reaction Comment Full text

ASURE SOFTWARE INC (ASUR)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Asure Software to Announce First Quarter 2026 Financial Results on April 30, 2026

Market reaction Comment Full text

CERUS CORP (CERS)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Market reaction Comment Full text

ALLOGENE THERAPEUTICS, INC. (ALLO)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

Market reaction Comment Full text

JANUX THERAPEUTICS, INC. (JANX)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

Market reaction Comment Full text

EYEPOINT, INC. (EYPT)

  • Business News
  • April 16, 2026, 20:01 UTC
  • 2
  • 1 comments

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Market reaction Comment Full text
  • Previous
  • 988
  • 989
  • 990
  • 991
  • 992
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(267869)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156118)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin